Biotech Products Services & Research, Inc. Launches General Surgical Subsidiary
Aimed to Increase Patient Referrals and Expand Product Marketing
(firmenpresse) - BAY HARBOR ISLAND, FL -- (Marketwired) -- 01/22/16 -- Biotech Products Services & Research, Inc. (OTCQB: BPSR) ("Biotech" or the "Company") is proud to announce the launch of its wholly-owned subsidiary, General Surgical Florida, Inc. ("General Surgical").
The team at General Surgical will work towards establishing sales distribution channels of regenerative products to hospitals, physicians and third party distributors. Specifically, General Surgical will be providing access to advanced regenerative medical technologies (e.g., adipocyte, bone marrow and placental regenerative tissues), and expanding education services to providers in the Company''s referral network.
Albert Mitrani, Biotech''s CEO, commented, "This new branch of Biotech, we believe, will increase the depth of the patient referral network in our associated Beyond Cells subsidiary, as well as set the stage for sales and distribution of future product lines. We look forward to providing further information about General Surgical as developments occur."
Biotech Products Services & Research Inc., a Nevada corporation, focuses on a lifestyle of health and wellness. Our vision is to be a vertically integrated company, which primarily provides a patient referral service for integrative cellular therapies. Biotech also markets cellular products to doctors and hospitals.
Biotech aims to be the leader in the industry of innovative cell-based therapeutic with our unique strategy which will guide a future of customized disease management. Biotech also sells women''s fashion products through its Ethan New York subsidiary as part of our vertically integrated health and wellness vision.
For more information investors can visit .
CAUTIONARY COMMENT REGARDING FORWARD-LOOKING STATEMENTS
The foregoing contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We intend for these forward-looking statements to be covered by the safe harbor provisions of the federal securities laws relating to forward-looking statements. This release contains forward-looking statements that reflect Biotech Products Services & Research, Inc., plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "goal" and similar expressions are used to identify forward-looking statements, representing management''s current judgment and expectations about possible future events.
Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company''s actual results, performance, achievements or financial position to be materially different from any expressed or implied by these forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements are set forth in our Form 10-K and other filings with the SEC. Other information can be obtained at
: This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
Biotech Products Services & Research, Inc.
1-888-417-8625
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.01.2016 - 08:43 Uhr
Sprache: Deutsch
News-ID 1410598
Anzahl Zeichen: 4125
contact information:
Contact person:
Town:
BAY HARBOR ISLAND, FL
Phone:
Kategorie:
Investment Services & Trading
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 201 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biotech Products Services & Research, Inc. Launches General Surgical Subsidiary
"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotech Products Services & Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
